Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Merz

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Journal of the American Geriatrics Society|September 1, 1995
Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancerD J Mazur, J F Merz
Accountability in Research|April 26, 2006
Evaluating the oversight of scientific misconductBarbara K Redman, Jon F Merz
Clinical Trials (London, England)|October 4, 2018
What gives them the right? Legal privilege and waivers of consent for researchFrancis X Baker, Jon F Merz
Nature|December 31, 1997
Patients and patentsM K Cho, J F Merz
Accountability in Research|November 28, 2006
Research misconduct policies of high impact biomedical journalsBarbara K Redman, Jon F Merz
Journal of the American Geriatrics Society|August 1, 1996
How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancerD J Mazur, J F Merz
Medical Care|September 13, 2002
Voluntariness of consent for research: an empirical and conceptual reviewRobert M Nelson, Jon F Merz
Community Genetics|October 26, 2005
What are gene patents and why are people worried about them?Jon F Merz, Mildred K Cho
Science (New York, N.Y.)|September 12, 1998
Testing for Alzheimer'sJ F Merz, M K Cho
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 28, 2022
A census of clinical trials conducted under the U.S. exception from informed consent ruleKrista L Snyder, Jon F Merz
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Journal of the American Geriatrics Society|September 1, 1995
Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancerD J Mazur, J F Merz
Accountability in Research|April 26, 2006
Evaluating the oversight of scientific misconductBarbara K Redman, Jon F Merz
Clinical Trials (London, England)|October 4, 2018
What gives them the right? Legal privilege and waivers of consent for researchFrancis X Baker, Jon F Merz
Nature|December 31, 1997
Patients and patentsM K Cho, J F Merz
Accountability in Research|November 28, 2006
Research misconduct policies of high impact biomedical journalsBarbara K Redman, Jon F Merz
Journal of the American Geriatrics Society|August 1, 1996
How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancerD J Mazur, J F Merz
Medical Care|September 13, 2002
Voluntariness of consent for research: an empirical and conceptual reviewRobert M Nelson, Jon F Merz
Community Genetics|October 26, 2005
What are gene patents and why are people worried about them?Jon F Merz, Mildred K Cho
Science (New York, N.Y.)|September 12, 1998
Testing for Alzheimer'sJ F Merz, M K Cho
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 28, 2022
A census of clinical trials conducted under the U.S. exception from informed consent ruleKrista L Snyder, Jon F Merz
Pageof 13